In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine.
about
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.Chloroquine inhibits dengue virus type 2 replication in Vero cells but not in C6/36 cellsNMR Structure of the SARS-CoV Nonstructural Protein 7 in Solution at pH 6.5Chloroquine could be used for the treatment of filoviral infections and other viral infections that emerge or emerged from viruses requiring an acidic pH for infectivitySevere acute respiratory syndrome coronavirus as an agent of emerging and reemerging infectionStructure and inhibition of the SARS coronavirus envelope protein ion channelIn vitro inhibition of human influenza A virus replication by chloroquine.A review of treatment modalities for Middle East Respiratory Syndrome.Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig modelThe management of coronavirus infections with particular reference to SARS.Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.Ethyl 5,8-dibromo-2-dibromo-methyl-6,7-dimeth-oxyquinoline-3-carb-oxy-late.Lack of protection against ebola virus from chloroquine in mice and hamstersOverview of antiviral and anti-inflammatory treatment for severe acute respiratory syndrome.Potential antivirals and antiviral strategies against SARS coronavirus infections.Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis.Chloroquine is effective against influenza A virus in vitro but not in vivo.Safe and Sensitive Antiviral Screening Platform Based on Recombinant Human Coronavirus OC43 Expressing the Luciferase Reporter Gene.Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice.Progress in Anti-SARS Coronavirus Chemistry, Biology and Chemotherapy.Hydroxychloroquine: from malaria to autoimmunity.Host Factors in Coronavirus Replication.Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseasesA time-of-drug addition approach to target identification of antiviral compounds.In Vitro Antiviral Activity of some Novel Isatin Derivatives against HCV and SARS-CoV Viruses.Repurposed Therapeutic Agents Targeting the Ebola Virus: A Systematic Review.BK Virus replication in vitro: limited effect of drugs interfering with viral uptake and intracellular transport.Different pH requirements are associated with divergent inhibitory effects of chloroquine on human and avian influenza A viruses.Chloroquine interferes with dengue-2 virus replication in U937 cells.Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice.Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies.Pyridine N-oxide derivatives are inhibitory to the human SARS and feline infectious peritonitis coronavirus in cell culture.Protein glycosylation in infectious disease pathobiology and treatmentPathobiology of virus glycosylation: implications to disease and prospects for treatmentChloroquine for the 2019 novel coronavirus SARS-CoV-2
P2860
Q24815979-5C74F6F5-4BB1-4677-8854-E5D9217F6D80Q26248879-19907900-25F4-4290-AAC1-BCCABF7159BAQ27664055-F1287917-1CBA-4D5B-8D67-0C282E0013B6Q28066142-0E6F6B9A-C83B-4BB8-A6C2-16D2084C7CD5Q28383088-A031ECF2-C0B6-4E99-B19A-679CC4CDCD79Q28475712-788392DE-0BCD-4070-9466-9F5FF6CE59E5Q30230591-6209DE47-CB28-4EC6-98D1-7980FAAAD52BQ30248209-117D3EAC-3AC9-42A6-9A34-AD3A08042CAAQ33617999-763200AA-1DB0-4C0C-B5C3-18DA7C25DD9FQ34012358-879C7AF8-66E9-444A-88B4-372AA0A0D5F5Q34058365-E040B59C-2E42-43B8-ACB8-B0A3A0BC2B8BQ34429967-F891C873-684C-4F0C-92DB-A2EC678D112FQ35673457-BBBD4DE9-F877-483D-ADC5-285B252789EEQ36140676-44374156-6AF9-489D-8679-ABBCF7184EC3Q36441511-5C4D6B98-C9A7-4F2B-A895-8D6A413926F3Q36844843-D0FF8EC5-47BB-430E-8112-9EA4F81FE20BQ37087650-BE4136C8-82F3-4611-820B-850D2DF009F0Q37203880-CFE866F3-18D0-4ED5-9F36-211115B8E396Q37274730-59DB3EDB-5C67-42DE-83D2-9E62B58EAB08Q37283689-7B497851-6EFB-4351-B88A-527F6AECD502Q37827403-9B074A43-DF21-4ADE-B096-D189A7C6992FQ38667715-6B1F04CF-B1A2-4BF8-9A1A-EA90EDC862DDQ39360987-1F483188-AFFE-406B-AF10-52E09808203EQ39531429-0D126E4D-C78B-4363-BA6B-7D2380FDA845Q39963152-71A9764B-2542-41D7-988E-3503346EDD15Q40045378-CC1F9E80-6FA3-45A4-93CD-B04C8D9E7F59Q40076684-AF3CEC94-1D50-4327-B6A6-E292A16E9ED5Q40137530-812E71CC-C0E3-401F-BFE5-7F0ED7842270Q40208955-938CDA88-0BFA-4D69-A444-51C49FAD3B9EQ41943954-21F778B6-AB5D-4732-A6B9-F6ED1788FA91Q43280688-CF795242-E514-4C73-8460-BD27A9FA941FQ46875163-5D5F7A71-7ADA-4465-A2CF-3322578CD136Q57202107-CCBEF705-6347-4552-B02C-46769B9ED15FQ57202110-876B17AC-00B4-4193-AD55-DEF03B716E54Q86911130-95baf39c-43b2-13ae-b96e-e5ff7b7e92fd
P2860
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine.
@en
type
label
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine.
@en
prefLabel
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine.
@en
P50
P1476
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine.
@en
P2093
Leen Vijgen
P304
P356
10.1016/J.BBRC.2004.08.085
P577
2004-10-01T00:00:00Z